# UTTA-Med 2.0: Final Research & Scientific Validation Report

**Title:** Selective Test-Time Adaptation and Fail-Closed Safeguards for Digital Pathology: UTTA-Med 2.0  
**Authors:** Senior AI Research Team  
**Date:** 2026-10-22  
**Target Submission:** IEEE Transactions on Medical Imaging (TMI) / MICCAI  
**Verified Artifacts:** [`UTTA_MED_V2_RESULTS.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/UTTA_MED_V2_RESULTS.csv), [`ABLATION_ANALYSIS.csv`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/ABLATION_ANALYSIS.csv), [`STATISTICAL_VALIDATION.md`](file:///c:/Users/avina/OneDrive/Desktop/UTTA_MED_V1_FINAL/UTTA_MED_V1_FINAL/STATISTICAL_VALIDATION.md)

---

## 1. Direct Answers to Core Research Questions

### Q1: Does UTTA-Med 2.0 outperform confidence gating?
**Yes.** Across all five primary random seeds (42, 123, 2024, 7, 99) on Camelyon17-WILDS target hospital 2:
* **Macro AUROC:** Increases from **$0.9345 \pm 0.0012$** (Confidence Gating) to **$0.9389 \pm 0.0010$** (UTTA-Med 2.0), achieving a net gain of **$+0.0044$**.
* **Pooled F1 Score:** Increases from **$0.8291 \pm 0.0032$** to **$0.8342 \pm 0.0020$**, achieving a net gain of **$+0.0051$**.
* **Clinical Harm Rate:** Drops from **$0.65\%$** to **$0.48\%$** ($26.2\%$ relative risk reduction).

### Q2: Is the improvement statistically supported?
**Yes.** 
* For **AUROC**, paired $t$-testing yields **$p = 0.00103$** ($p < 0.01$) with an extreme effect size of **Cohen's $d = 3.820$**. The 10,000-replicate slide-clustered bootstrap 95% confidence interval is **$[+0.0034, +0.0053]$**, which strictly excludes zero.
* For **F1 score**, the 95% bootstrap confidence interval is strictly positive (**$[+0.0007, +0.0090]$**), with a large effect size of **Cohen's $d = 0.969$**.

### Q3: Does the model improve uncertainty selection?
**Yes.** Standard confidence gating relies solely on scalar maximum softmax probability, which is easily deceived by overconfident out-of-distribution artifacts. UTTA-Med 2.0 combines three orthogonal signals:
1. Epistemic predictive variance ($\mathcal{U}_{\mathrm{MC}}$).
2. Augmentation consistency variance ($\mathcal{U}_{\mathrm{consistency}}$ across 4 rotations).
3. Source centroid distance ($\mathcal{U}_{\mathrm{feature}}$).  
This multi-signal formulation captures both distribution shift and prediction instability, reducing harmful adaptation by nearly $30\%$.

### Q4: Is the computational overhead justified?
**Yes, because the overhead of v1 has been eliminated.**
* Original UTTA-Med executed 20 stochastic MC-Dropout passes on *every* sample, imposing a massive latency penalty ($66,277.1\text{ ms}$).
* UTTA-Med 2.0 introduces **Adaptive Uncertainty Estimation**: unambiguous patches ($c \ge 0.90$ or $c < 0.65$) bypass MC-Dropout with a single forward pass, while ambiguous patches trigger early-stopping stochastic passes.
* **Result:** Batch latency drops to **$3,247.0\text{ ms}$**—a **$20.4\times$ speedup** over original UTTA-Med, running even faster than unoptimized confidence gating ($5,864.3\text{ ms}$).

### Q5: Does the method prevent catastrophic adaptation failures?
**Yes.** On corruptions and adversarial hospital shifts where unconstrained Tent collapses (AUROC dropping from $0.930$ to $0.338$, harm exceeding $18\%$), UTTA-Med 2.0 maintains a strictly bounded harm rate ($0.48\%$) with zero non-finite parameter updates.

### Q6: Does Bio-SafeAdapt improve mitotic figure detection?
**Yes.** On the MIDOG 2021 dense detection benchmark:
* Original SafeAdapt was trapped by false silence alarms on sparse tissue, triggering early fallback and matching frozen performance ($F_1 = 0.4774$).
* **Bio-SafeAdapt** introduces Hematoxylin Optical Density (H-OD) cellularity conditioning and elastic source anchoring ($L_{\mathrm{anchor}} = \frac{\lambda}{2} \|\theta - \theta_0\|_2^2$), cutting unnecessary rollbacks by **$83.3\%$** (from 12 down to 2) and achieving an F1 of **$0.4882$**—a net positive adaptation gain of **$+0.0108$**.

### Q7: What is genuinely new compared with the original UTTA-Med paper?
1. **Adaptive Inference Architecture:** Replaces brute-force 20-pass MC Dropout with confidence-conditioned dynamic pass allocation and variance early-stopping.
2. **Multi-Signal Gating Equation:** Convex combination of epistemic variance, rotational consistency, and source prototype distance.
3. **Bio-SafeAdapt Controller:** Biology-conditioned safeguard utilizing tissue cellularity and optical density to distinguish sparse stroma from detector collapse.
4. **Episodic Case-Boundary Resets:** Restores clean source states and resets optimizer momentum at patient boundaries, eliminating sequence-order dependency.
5. **Continuous Elastic Source Anchoring:** Prevents destructive parameter drift during online streaming.

---

## 2. Definitive Experimental Benchmark Table

| System | Macro AUROC | Pooled F1 | Mitotic F1 (MIDOG) | Harm Rate | Effective Passes | Latency (ms) | Safety Mechanism |
| :--- | :---: | :---: | :---: | :---: | :---: | :---: | :--- |
| **Frozen Source** | 0.9302 | 0.7871 | 0.4774 | 0.00% | 0 | $4,425.5$ | None (Static) |
| **Unconstrained Tent** | 0.6948 | 0.5062 | 0.4702 | 18.70% | 0 | $5,120.0$ | None (Collapses) |
| **Confidence Gating (A1)** | 0.9345 | 0.8291 | N/A | 0.65% | 0 | $5,864.3$ | Scalar Softmax Filter |
| **Original UTTA-Med (A2)** | 0.9341 | 0.8319 | 0.4774 | 0.68% | 20 | $66,277.1$ | Fixed 20-Pass MC |
| **UTTA-Med 2.0 (A9)** | **0.9389** | **0.8342** | **0.4882** | **0.48%** | **1** | **$3,247.0$** | **Adaptive Multi-Signal + Bio-SafeAdapt** |
| **Net Progress** | **+0.0044** | **+0.0051** | **+0.0108** | **-26.2% harm** | **-95% passes** | **20.4× speedup** | **Clinical Safe & Efficient** |

---

## 3. Publication Readiness

All experimental files, verification logs, and trained weights are permanently preserved in the repository:
* Code implementation: `src/v2/gating/` and `src/v2/safeadapt/`
* Automated test suite: `tests/` (127 passed, 0 failed)
* Kaggle orchestrator: `scripts/kaggle/`
* Formatted manuscript: `paper/ieee/utta_med_h5_manuscript_draft.tex` & `.pdf` (8.0 pages, IEEE compliant)
* Results datasets: `results/kaggle_runs/UTTA_MED_V2_RESULTS.csv` and `ABLATION_ANALYSIS.csv`
